We aimed to assess whether GCKR rs780094 C→T SNP influences the expression of steatosis, lobular inflammation and fibrosis in NAFLD patients, after correction for PNPLA3 genotype. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.